Header Logo

Connection

HOWARD WEINER to Administration, Cutaneous

Back to Details
This is a "connection" page, showing publications HOWARD WEINER has written about Administration, Cutaneous.
HOWARD WEINER
Connection Strength
0.047
Administration, Cutaneous
  1. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet. 2012 Nov 24; 380(9856):1829-39.
    View in: PubMed
    Score: 0.024
  2. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet. 2012 Nov 24; 380(9856):1819-28.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.